ETCTN10204
10204: A Phase 1b Study of Nivolumab in Patients with Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)
Sites: Johns Hopkins Kimmel Cancer Center in Baltimore
J1380
A biospecimen bank and study to understand genitourinary cancer and other benign urologic conditions.
Sites: Johns Hopkins Kimmel Cancer Center in Baltimore, Johns Hopkins Bayview Medical Center, Sibley Memorial Hospital
J17187
Phase II Trial of Rucaparib in Patients with Metastatic and Non-Metastatic Hormone-Sensitive Prostate Cancer Harboring DNA Repair Gene Mutations (TRIUMPH)
Sites: Johns Hopkins Kimmel Cancer Center in Baltimore
J18106
A Phase 1/1b multicenter study to evaluate the humanized anti-CD 73 antibody, CPI-006, as a single agent, or in combination with Ciforadenant with Pembrolizumab, and with Ciforadenant plus pembrolizumab in adult subjects with advanced cancers (CPI-006-001)
Sites: Johns Hopkins Kimmel Cancer Center in Baltimore
J18161
J18161-ADaptiVe Biomarker Trial that InformS Evolution of Therapy (ADVISE)
Sites: Johns Hopkins Kimmel Cancer Center in Baltimore
J20120
A Phase I/II, First-In-Human, Multi-Part, OpenLabel, Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of DF1001 in Patients With Locally Advanced or Metastatic Solid Tumors, and Expansion in Selected Indications (DF1001-001)
Sites: Johns Hopkins Kimmel Cancer Center in Baltimore
J2020
A Phase II trial for the use of Intravesical Gemcitabine and Docetaxel (GEMDOCE) in the treatment of BCG naïve Non-muscle invasive Urothelial Carcinoma of the Bladder
Sites: Johns Hopkins Kimmel Cancer Center in Baltimore
J2139
A Phase 2 Study to Evaluate the Efficacy and Safety of belzutifan (MK-6482, formerly PT2977) Monotherapy in Participants with Advanced Pheochromocytoma/Paraganglioma (PPGL) and Pancreatic Neuroendocrine Tumor (pNET) (015-00)
Sites: Johns Hopkins Kimmel Cancer Center in Baltimore
J2170
A study of intravesical enfortumab vedotin for treatment of patients with non-muscle invasive bladder cancer (NMIBC) [EV-104]
Sites: Johns Hopkins Kimmel Cancer Center in Baltimore
NCTNS1806
S1806 Phase III Randomized Trial of Concurrent Chemoradiotherapy with or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer